文献速递创伤骨科骨质疏松与代谢性骨病

髋部骨折后引入医嘱套餐改善骨质疏松药物启动与持续性:一项基于人群的前后分析

Introduction of an order set after hip fracture improves osteoporosis medication initiation and persistence: a population-based before-after analysis.
PubMed 文献 · Osteoporos Int · 2024-06-05

该研究在加拿大曼尼托巴省一家医院2015年引入髋部骨折医嘱套餐(OS),并与同地区其他医院对照,采用回顾性队列分析2010-2019年50岁以上低能量髋部骨折手术患者。结果显示OS组抗骨质疏松药物启动率从16.7%升至48.6%,1年持续性从17.7%升至28.4%,但两组继发骨折无显著差异(19.8% vs 18.8%,p=0.38)。

要点

  • 髋部骨折医嘱套餐使抗骨质疏松药物启动率由16.7%升至48.6%(p<0.001)。
  • 医嘱套餐使1年药物持续性由17.7%升至28.4%(p<0.001)。
  • 继发骨折OS组19.8% vs 对照组18.8%,无显著差异(p=0.38)。

核心结论

  • 引入髋部骨折医嘱套餐显著提高了抗骨质疏松药物的启动率和骨折后1年持续性。
  • 继发骨折方面未见显著差异。

研究设计与样本

  • 回顾性队列研究,使用关联行政健康数据。
  • 2015年加拿大曼尼托巴省一家医院引入髋部骨折医嘱套餐(OS组),对照来自同地区其他医院。
  • 纳入2010至2019年间因低能量髋部骨折接受手术的50岁及以上个体,OS组813例,对照组2150例。

主要发现

  • OS组抗骨质疏松药物启动率:引入前一年16.7% vs 引入后一年48.6%(p<0.001),对照组无变化。
  • OS组1年药物持续性:引入前一年17.7% vs 引入后一年28.4%(p<0.001)。
  • 继发骨折:OS组19.8% vs 对照组18.8%(p=0.38),无显著差异。
  • 两组在人口学、社会经济因素或合并症方面无基线差异。

关键数值与推荐

  • 组间年度差异采用卡方检验。
  • 采用逻辑回归模型检验社会人口学和临床因素对药物启动及持续性的影响。
  • 采用Cox回归检验继发骨折风险。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: We found that a standardized order set after hip fracture increased initiation of anti-osteoporosis medication and increased persistence at 1 year, but did not reduce secondary fractures. BACKGROUND: A treatment gap exists after osteoporosis-related fractures. Introducing standardized care can improve treatment. We evaluated the impact of a hip fracture order set (OS) on anti-osteoporosis medication (AOM) initiation, persistence, and secondary fracture prevention. METHODS: In 2015, one hospital in Manitoba, Canada, introduced a hip fracture OS including recommendations for the initiation of AOM (OS group). A control group was identified from the other hospitals in the same region. A retrospective cohort study was conducted using linked administrative health data. All individuals 50 + years with surgical treatment for low-energy hip fracture between 2010 and 2019 were included and followed for AOM initiation, medication persistence at 1 year, and secondary fractures. Between-group differences for each year were assessed using chi-square tests. Logistic regression models tested the impact of socio-demographic and clinical factors on initiation, persistence of AOM. Cox regression tested the risk of secondary fracture. RESULTS: No baseline differences between OS group (813 patients) and control group (2150 patients) were observed in demographics, socioeconomic factors, or comorbidities. An increase in post-fracture AOM initiation was seen with OS introduction (OS group year before 16.7% versus year after 48.6%, p < 0.001). No change was seen in the control group. Persistence on AOM also increased (OS group year before 17.7% versus year after 28.4%, p < 0.001). No difference in secondary fractures was observed (OS group 19.8% versus control group 18.8%, p = 0.38). CONCLUSION: Introduction of a hip fracture OS significantly increased AOM initiation and persistence at 1-year post-fracture. There was no significant difference in secondary fractures.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Larose G, Al-Azazi S, Lix LM, et al. Introduction of an order set after hip fracture improves osteoporosis medication initiation and persistence: a population-based before-after analysis. Osteoporos Int. 2024. PMID: 38836945. doi:10.1007/s00198-024-07131-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。